PharmiWeb.com - Global Pharma News & Resources

Clinical research - Press Releases

Date Title Company
29-Sep-2022 Dr. Vince Clinical Research Opens Industry-Leading Clinical Pharmacology Unit Dr. Vince Clinical Research
28-Sep-2022 Velocity Clinical Research reveals findings from US patient survey on decentralization in clinical research Velocity Clinical Research
26-Sep-2022 Genetically modified herpes virus delivers one-two punch against advanced cancers The Institute of Cancer Research
26-Sep-2022 Research identifies new treatment target for CNS injury and neurological disease Science Advances
26-Sep-2022 Immutep receives AUD 2.7 million research and development tax incentive from French government Immutep
26-Sep-2022 Paige and OptraSCAN Partner to Streamline Digital Pathology Adoption OptraSCAN Inc
22-Sep-2022 Bullet, Nail & Bolt: Penetrating Brain Injuries in Austria Karl Landsteiner University of Health Sciences
22-Sep-2022 Kancera reports convincing preclinical results and decision to initiate clinical development of KAND567 in ovarian cancer Kancera
22-Sep-2022 Almirall announces the initiation of a Phase I study of anti-IL-1RAP first-in-class monoclonal antibody for autoimmune dermatological diseases Almirall
22-Sep-2022 SMART and NTU Singapore develop a quick test kit to determine a person’s immunity against COVID-19 and its variants Blue Totem Communications
21-Sep-2022 Tower to bring the temperature of pharmaceutical logistics to CPhI Tower Cold Chain
20-Sep-2022 Rapid growth puts Australian CRO Accelagen on the map for clinical research globally Accelagen
11-Sep-2022 Blood Clot Retrieval Devices Market Size Will Achieve USD 5.6 Billion By 2030 Growing At 18.4% CAGR - Exclusive Report by Acumen Research and Consulting Acumen Research And Consulting
07-Sep-2022 ABBOTT ANNOUNCES EUROPEAN LAUNCH OF AMPLATZER™ TALISMAN™ SYSTEM TO CLOSE HOLE IN HEART FOR PEOPLE AT RISK OF RECURRENT STROKE Abbott
07-Sep-2022 KITE’S CAR T-CELL THERAPY TECARTUS® (BREXUCABTAGENE AUTOLEUCEL) GRANTED EUROPEAN MARKETING AUTHORISATION FOR THE TREATMENT OF RELAPSED OR REFRACTORY ACUTE LYMPHOBLASTIC LEUKAEMIA (r/r ALL) KITES
07-Sep-2022 Velocity Clinical Research growth skyrockets with eight site acquisitions Velocity Clinical Research
07-Sep-2022 HTC VIVE Introduces VIVE Focus 3 Facial Tracker and Eye Tracker HTC VIVE
07-Sep-2022 KITE’S CAR T-CELL THERAPY TECARTUS® (BREXUCABTAGENE AUTOLEUCEL) GRANTED EUROPEAN MARKETING AUTHORISATION FOR THE TREATMENT OF RELAPSED OR REFRACTORY ACUTE LYMPHOBLASTIC LEUKAEMIA (r/r ALL) KITE’S
07-Sep-2022 BRAIN TUMOR: ANTI EPILEPTIC DRUG PROMISING & TOLERABLE St. Pölten/Krems
07-Sep-2022 Radiology technology start-up Hexarad raises further £2.2m to complete Series A funding Radiology technology